6th Circ. Affirms Toss Of Generic Drug Labeling Suits

Law360, New York (September 22, 2011, 6:51 PM EDT) -- The Sixth Circuit on Thursday upheld the dismissal of three suits bringing state failure-to-warn claims related to generic versions of heartburn medication Reglan against Barr Pharmaceuticals Inc. and others, citing the U.S. Supreme Court's recent decision in Pliva Inc. v. Mensing.

A three-judge panel ruled that a Western District of Kentucky judge had correctly decided in 2008 to nix three suits accusing both generic-drug makers as well as the drug's brand-name manufacturers of failing to include adequate information on their product labels concerning the risk that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.